secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001437749-24-033673
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife completes $50M acquisition of Electrochem Solutions; secures $55M term loan
--------------------------------------------------------------------------------

- Acquired all shares of Electrochem from Integer Holdings (NYSE: ITGR) for $50M cash on Oct 31, 2024.
- Electrochem designs primary lithium metal and ultracapacitor cells; trailing 12-month revenue of $34M.
- Funded via new $55M senior secured term loan from KeyBank, M&T, and Community Bank, maturing Oct 31, 2029.
- CEO Mike Manna expects cross-selling opportunities, scale efficiencies, and expanded market reach.
- Financial statements and pro forma financial information to be filed within 71 days of this report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774924033673/0001437749-24-033673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774924033673/ulbi20241105_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-033673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer